ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Magnetic resonance imaging (MRI)"

  • Abstract Number: 2254 • ACR Convergence 2022

    Detection of Active Inflammatory and Structural Changes Indicative of Axial Spondyloarthritis on MRI of Sacroiliac Joint Using a Deep Learning Framework

    Keno Kyrill Bressem1, Lisa Adams1, Fabian Proft2, Kay-Geert Hermann3, Torsten Diekhoff1, Laura Spiller1, Stefan Niehues1, Marcus Makowski4, Bernd Hamm1, Mikhail Protopopov5, valeria Rios-Rodriguez6, Hildrun Haibel7, Judith Rademacher5, Murat Torgutalp7, Robert G Lambert8, Xenofon Baraliakos9, Walter P Maksymowych10, Janis Vahldiek1 and Denis Poddubnyy2, 1Charité – Universitätsmedizin Berlin, Berlin, Germany, 2Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 3Charité - Universitätsmedizin Berlin, Berlin, Germany, 4Technical University of Munich, Munich, Germany, 5Charité Universitätsmedizin Berlin, Berlin, Germany, 6Charité-Universitätsmedizin Berlin, Berlin, Germany, 7Charité - Universitätsmedizin, Berlin, Berlin, Germany, 8University of Alberta, Edmonton, AB, Canada, 9Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 10Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Magnetic resonance tomography (MRI) plays a key role in the early diagnosis of axial spondyloarthritis (axSpA). However, the detection of changes indicative of axSpA…
  • Abstract Number: 0408 • ACR Convergence 2022

    Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non‑Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status

    Philip C. Robinson1, Walter P Maksymowych2, Lianne Gensler3, Martin Rudwaleit4, Bengt Hoepken5, Lars Bauer5, Thomas Kumke5, Mindy Kim6 and Atul Deodhar7, 1University of Queensland School of Clinical Medicine, Brisbane, Australia, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, CA, 4University of Bielefeld, Klinikum Bielefeld, Bielefeld; Germany Klinikum Bielefeld and Charité Berlin, Germany, and Gent University, Gent, Belgium, 5UCB Pharma, Monheim am Rhein, Germany, 6UCB Pharma, Smyrna, GA, 7Oregon Health & Science University, Portland, OR, USA, Portland, OR

    Background/Purpose: Certolizumab pegol (CZP) has demonstrated clinical efficacy in patients (pts) with active non-radiographic axial spondyloarthritis (nr-axSpA) and objective signs of inflammation (OSI) during the…
  • Abstract Number: 1243 • ACR Convergence 2022

    The Impact of MRI Slice Thickness on the Detection of Spinal Syndesmophytes in Axial Spondyloarthritis

    Kalliopi Klavdianou1, Alexaner Dieter Mewes2, Styliani Tsiami3, Philipp Sewerin4 and Xenofon Baraliakos5, 1'Asklepieion' General Hospital, Department of Rheumatology, Voula, Athens, Greece, 2University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany, 3Rheumazentrum Ruhrgebiet, Herne, Ruhr-University Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Conventional radiographs (CR) are the gold standard for detecting syndesmophytes in axial Spondyloarthritis (axSpA), mainly because magnetic resonance imaging (MRI) is not able to…
  • Abstract Number: 2255 • ACR Convergence 2022

    Do Fatty Lesions Explain the Association Between Inflammation and New Syndesmophytes in Patients with Radiographic Axial Spondyloarthritis?

    Rosalinde Stal1, Alexandre Sepriano2, Sofia Ramiro1, floris van Gaalen1, Pedro Machado3, Xenofon Baraliakos4, Manouk de Hooge5, Rosaline van den Berg1, Monique Reijnierse1, Juergen Braun6, Robert Landewé7 and Désirée van der Heijde8, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Centre, Portela Loures, Portugal, 3University College London, London, United Kingdom, 4Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 5Ghent University Hospital, Luxembourg, Luxembourg, 6Rheumazentrum Ruhrgebiet, Herne, Germany, 7Amsterdam University Medical Center, Meerssen, Netherlands, 8Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands

    Background/Purpose: Presence of vertebral corner inflammation (VCI) increases the likelihood of a new syndesmophyte in the same vertebral corner (VC) in patients with r-axSpA. It…
  • Abstract Number: 0419 • ACR Convergence 2022

    Efficacy of Upadacitinib in Patients with Non-Radiographic Axial Spondyloarthritis Stratified by Objective Signs of Inflammation at Baseline

    Walter P Maksymowych1, Xenofon Baraliakos2, Atul Deodhar3, Denis Poddubnyy4, Fabiana Ganz5, Tianming Gao6, Jayne Stigler6, Anna K Shmagel6, Peter Wung6 and Filip Van den bosch7, 1Department of Medicine, University of Alberta, Edmonton, AB, Canada, 2Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 3Oregon Health & Science University, Portland, OR, USA, Portland, OR, 4Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 5AbbVie, Inc., Luzern, Switzerland, 6AbbVie, Inc., North Chicago, IL, 7Department of Internal Medicine and Paediatrics, Ghent University and VIB Centre for Inflammation Research, Ghent, Belgium

    Background/Purpose: The Phase 3 SELECT-AXIS 2 trial (NCT04169373) assessed the efficacy and safety of upadacitinib (UPA) in patients with non-radiographic axial spondyloarthritis (nr-axSpA). Here, we…
  • Abstract Number: 1248 • ACR Convergence 2022

    A Retrospective Chart Review Examining How a Change in MRI Protocol Could Affect the Diagnosis of Axial Spondyloarthritis

    Alexa Kouroukis1, Manisha Mulgund2, Leilani Famorca3, Pauline Boulos1 and Viktoria Pavlova4, 1McMaster University, Hamilton, ON, Canada, 2Trillium Health Partners, Ancaster, ON, Canada, 3McMaster University, Milton, ON, Canada, 4McMaster University, Ancaster, ON, Canada

    Background/Purpose: St. Joseph's Healthcare Hamilton (SJHH) recently changed their MRI-axial spondyloarthritis (axSpA) protocol, used to diagnose patients with axSpA, from an MRI of the spine…
  • Abstract Number: 2257 • ACR Convergence 2022

    MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis

    Walter P Maksymowych1, Mikkel Østergaard2, Xenofon Baraliakos3, Pedro Machado4, Susanne J. Pedersen5, Ulrich Weber6, Iris Eshed7, Manouk de Hooge8, Joachim Sieper9, Denis Poddubnyy10, Martin Rudwaleit11, Désirée van der Heijde12, Robert Landewé13 and Robert G Lambert14, 1Department of Medicine, University of Alberta, Edmonton, AB, Canada, 2Rigshospitalet, University of Copenhagen, Glostrup, Denmark, 3Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 4University College London, London, United Kingdom, 5Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 6Practice Buchsbaum Schaffhausen, Schaffhausen, Switzerland, 7Sheba Medical Center, Tel Aviv, Israel, 8Ghent University Hospital, Luxembourg, Luxembourg, 9Charité - Universitätsmedizin, Berlin, Berlin, Germany, 10Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 11University of Bielefeld, Klinikum Bielefeld, Bielefeld; Germany Klinikum Bielefeld and Charité Berlin, Germany, and Gent University, Gent, Belgium, 12Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 13Amsterdam University Medical Center, Meerssen, Netherlands, 14University of Alberta, Edmonton, AB, Canada

    Background/Purpose: There is limited data as to the frequency of spinal lesions on MRI in patients without MRI or radiographic features typical of sacroiliac joint…
  • Abstract Number: 0473 • ACR Convergence 2022

    Comprehensive Assessment of Cranial and Orbital Vasculature on MRI in Patients with Giant Cell Arteritis

    Rennie Rhee, Shubhasree Banerjee, Vatsal Bhatt, Madhura Tamhankar, Naomi Amudala, Sherry Chou, Morgan Burke, Laurie Loevner, Peter Merkel and Jae Song, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Vessel wall MRI depicts changes consistent with arterial wall inflammation. Unlike temporal artery biopsy, MRI visualizes several full-length cranial arteries in a single scan…
  • Abstract Number: 1255 • ACR Convergence 2022

    Rheumatologists Overcall Sacroiliitis on X-ray and MRI in Axial Spondyloarthritis Patients: Data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT (Be-GIANT)

    Ann-Sophie Kathleen De Craemer1, Manouk de Hooge2, Thomas Renson3, Liselotte Deroo4, Gaelle Varkas3, Liesbet Van Praet5, Rik Joos6, Jan Lenaerts7, Mieke Devinck8, Lieve Gyselbrecht9, isabelle peene3, Kristof Thevissen10, Philippe Carron3, Filip Van den bosch11 and Dirk Elewaut12, 1Ghent University Hospital, Gent, Belgium, 2Ghent University Hospital, Luxembourg, Luxembourg, 3Ghent University Hospital, Ghent, Belgium, 4Ghent University, Gent, Belgium, 5AZ Maria Middelares, Ghent, Belgium, 6Ghent University Hospital, Basel, Switzerland, 7Reuma Instituut Hasselt, Hasselt, Belgium, 8AZ Sint-Lucas, Brugge, Belgium, 9ASZ Aalst, Aalst, Belgium, 10Reumacentrum Genk, Genk, Belgium, 11Department of Internal Medicine and Paediatrics, Ghent University and VIB Centre for Inflammation Research, Ghent, Belgium, 12Department of Rheumatology, Ghent University Hospital, Belgium, VIB-UGent Center for Inflammation Research, Ghent University, Heusden, Belgium

    Background/Purpose: To investigate (1) agreement between local and central reading of sacroiliac joint images (X-ray and magnetic resonance imaging [MRI]) from axial spondylarthritis (axSpA) patients,…
  • Abstract Number: 2258 • ACR Convergence 2022

    Relative Frequencies of the Spectrum of MRI Lesions in the Sacroiliac Joints of Healthy Individuals and Patients with Non-Specific Back Pain: What Is the Impact of Increasing Age?

    Ulrich Weber1, Susanne Pedersen2, Mikkel Østergaard3, Pedro Machado4, Xenofon Baraliakos5, Robert G Lambert6 and Walter P Maksymowych7, 1Practice Buchsbaum Schaffhausen, Schaffhausen, Switzerland, 2Rigshospitalet, København, Denmark, 3Rigshospitalet, University of Copenhagen, Glostrup, Denmark, 4University College London, London, United Kingdom, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 6University of Alberta, Edmonton, AB, Canada, 7Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Previous studies of patients with axial spondyloarthritis (axSpA) have demonstrated that certain MRI structural lesions in the sacroiliac joints (SIJ), notably erosions, has high…
  • Abstract Number: 0230 • ACR Convergence 2021

    Fatigue and Inflammation in Rheumatoid Arthritis Are Already Disconnected Before Clinical Arthritis Develops

    Sarah J.H. Khidir1, Annette H.M van der Helm-van Mil1 and Elise van Mulligen2, 1Leiden University Medical Center, Leiden, Netherlands, 2Erasmus Medical Center, Rotterdam, Netherlands

    Background/Purpose: Fatigue is disabling and common in Rheumatoid Arthritis (RA); the causation of fatigue in RA is multidimensional and only partially explained by inflammation. The…
  • Abstract Number: 0921 • ACR Convergence 2021

    Effect of Secukinumab on Radiographic Progression and Inflammation in Sacroiliac Joints and Spine in Patients with Non-radiographic Axial Spondyloarthritis: 2-year Imaging Outcomes from a Phase III Randomized Trial

    Juergen Braun1, Ricardo Blanco2, Helena Marzo-Ortega3, Lianne Gensler4, Filip Van den Bosch5, Stephen Hall6, Hideto Kameda7, Denis Poddubnyy8, Marleen van de Sande9, Désirée van der Heijde10, Tingting Zhuang11, Anna Stefanska12, Aimee Readie11, Hanno Richards13 and Atul Deodhar14, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Hospital University Marqués de Valdecilla, IDIVAL, Division of Rheumatology, Santander, Spain, 3NIHR Leeds Biomedical Research Centre and University of Leeds, Leeds, United Kingdom, 4Department of Rheumatology, University of California San Francisco, San Francisco, CA, 5Dept. of Rheumatology - Ghent University Hospital, Ghent, Belgium, Ghent, Belgium, 6Emeritus Research and Monash University, Melbourne, Australia, Melbourne, Australia, 7Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Tokyo, Japan, 8Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 9Amsterdam UMC, University of Amsterdam, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, 10Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 11Novartis Pharmaceuticals Corporation, East Hanover, NJ, 12Novartis Ireland Limited, Dublin, Ireland, Dublin, Ireland, 13Novartis Pharma AG, Basel, Switzerland, 14Oregon Health & Science University, Portland, OR

    Background/Purpose: Axial spondyloarthritis (axSpA) is characterized by inflammation of the sacroiliac joints (SIJ) and the spine. Secukinumab (SEC) treatment was clinically efficacious and reduced SIJ…
  • Abstract Number: 0305 • ACR Convergence 2021

    Artificial Neural Networks Approaches to Predict Myocardial Fibrosis in Primary Sjögren Syndrome Patients Without Cardiac Symptoms

    Hitomi Kobayashi1, Yasuyuki Kobayashi2, Atsuma Nishiwaki1, Isamu Yokoe1, Haraoka Masaki3, Eichi Takaya3, Yousuke Nagasawa1, Noboru Kitamura1, Masami Takei1 and Hideki Nakamura1, 1Nihon University School of Medicine, Itabashi, Japan, 2St. Marianna University School of Medicine, kowasaki, Japan, 3St. Marianna University School of Medicine, Kawaski, Japan

    Background/Purpose: A recent meta-analysis of cardiovascular diseases demonstrated that the odds of heart failure (HF) was more than 2.54-fold higher in primary Sjögren syndrome (pSS)…
  • Abstract Number: 0930 • ACR Convergence 2021

    Effect of Tofacitinib on Spinal Vertebral Body and Posterolateral Element Inflammation and Structural Lesions Using the Canada-Denmark MRI Scoring System in Patients with Ankylosing Spondylitis: Results from a Phase 2 Study

    Mikkel Ostergaard1, Joseph Wu2, Lara Fallon3, Sarah P Sherlock4, Cunshan Wang2, Dona L Fleishaker2, Keith S Kanik2 and Walter Maksymowych5, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, University of Copenhagen, Glostrup, Denmark, 2Pfizer Inc, Groton, CT, 3Pfizer Canada, Montréal, QC, Canada, 4Pfizer Inc, Cambridge, MA, 5Department of Medicine, University of Alberta, Alberta, Canada, Edmonton, AB, Canada

    Background/Purpose: The Canada-Denmark (CANDEN) MRI scoring system enables detailed anatomy-based evaluation of inflammatory and structural lesions in spinal vertebral bodies and posterior elements in patients…
  • Abstract Number: 0364 • ACR Convergence 2021

    Dose Tapering of TNF Inhibitors in Patients with Axial Spondyloarthritis in Routine Care – 2-year Clinical and MRI Outcomes and Predictors of Successful Tapering

    Marie Wetterslev1, Stylianos Georgiadis2, Inge Juul Sørensen3, Susanne Juhl Pedersen2, Sara Nysom Christiansen4, Merete Lund Hetland1, Cecilie Heegaard Brahe2, Mads Bakkegaard5, Anne Duer6, Mikael Boesen7, Kasper Kjærulf Gosvig8, Jakob Møllenbach Møller8, Niels Steen Krogh9, Bente Jensen5, Ole Rintek Madsen5, Jan Christensen5, Annette Hansen5, Jesper Nørregaard5, Henrik Røgind5 and Mikkel Ostergaard10, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, 2Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, 3Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 4Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 5Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, 6Department of Radiology, Rigshospitalet, Glostrup, Copenhagen, Denmark, 7Department of Radiology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 8Department of Radiology, Herlev and Gentofte Hospital, Copenhagen, Denmark, 9ZiteLab ApS, Copenhagen, Denmark, Frederiksberg, Denmark, 10Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, University of Copenhagen, Glostrup, Denmark

    Background/Purpose: In a 2-year follow-up study of patients with axial spondyloarthritis (axSpA) in clinical remission who tapered Tumor Necrosis Factor inhibitor (TNFi) treatment according to…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 26
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology